Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Editorials
You have accessRestricted Access

Acute Kidney Injury and Chronic Kidney Disease: A Work in Progress

Jason R. Bydash and Areef Ishani
CJASN November 2011, 6 (11) 2555-2557; DOI: https://doi.org/10.2215/CJN.09560911
Jason R. Bydash
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Areef Ishani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Short-term outcomes of acute kidney injury (AKI), such as length of hospital stay and inpatient mortality, are well documented. Recently, the impact of AKI on long-term outcomes—a largely undefined body of knowledge—has come into focus. Evidence associating AKI in the inpatient setting with extended outcomes of mortality and the development of chronic kidney disease (CKD) has materialized. Several studies have linked severity of AKI with increased likelihood of mortality, developing end-ESRD, or chronic kidney disease (1–3). Others have found an association between temporary dialysis support for AKI in CKD patients and progression to ESRD (4).

The detrimental effect of AKI episodes on the development and progression of CKD has been explored in animal models. For instance, Nath et al. found that repetitive nephrotoxic insults over time results in chronic renal disease in rats (7). Furthermore, Basile et al. found persistent changes at the gene transcription level in the kidneys of rats subjected to ischemic insult, even after serum creatinine levels had recovered to match those of untreated controls (8). These findings support the clinical findings associating AKI episodes with progressive kidney disease.

A review of the recent literature reveals several studies linking AKI to the progression of kidney disease, five of which are presented in Table 1. Of the five presented, the length of studies ranged from 3.3 to 8 years in various settings. With regard to outcomes, three out of five studies used ESRD as the primary outcome, two used progression of CKD as the outcome, and one used incident CKD. In general, all studies demonstrate an increased risk of adverse renal outcomes, irrespective of how AKI was defined. For example, of the studies using ESRD as their primary outcome, the hazard associated with an AKI episode ranged from 1.45 to 11.74 (2–6). Unfortunately, the role of recurrent AKI on development and progression of CKD remains underexplored in the clinical realm. Most recent studies have examined the impact of one episode of acute kidney injury on patient outcomes. In the current issue of CJASN, Thakar and colleagues examine the association between solitary and multiple AKI episodes and the risk of chronic kidney disease in a cohort of diabetic patients (9).

View this table:
  • View inline
  • View popup
Table 1.

Recent studies linking AKI to long-term outcomes

Briefly, Thakar et al. studied a cohort of 4082 patients with diabetes who sought ambulatory and inpatient treatment within the Veterans Affairs healthcare system between January 1, 1999, and December 31, 2004, and followed them until December 31, 2008. Prospective patients were identified as having diabetes, based on ICD-9 codes, during at least one outpatient clinic encounter. After excluding patients with fewer than three creatinine levels or an eGFR <30 ml/min per 1.73 m2 at the time of first creatinine measurement, 3679 patients remained for evaluation. AKI was defined according to the Acute Kidney Injury Network criteria. A total of 1822 patients required at least one hospitalization, 530 of 1822 patients experienced one AKI episode, and 158 of 530 patients experienced two or more AKI episodes. The mean age of patients in the study was 61.7 years, mean baseline creatinine was 1.10 mg/dl, and mean time of observation was 61.2 months. The study's findings reveal a significantly increased hazard of developing stage 4 CKD and mortality in individuals suffering from AKI during hospitalization compared with individuals without AKI. In addition, each additional AKI episode (up to three total) was associated with an independent and cumulative increase in the risk for the development of stage 4 CKD (hazard ratio = 2.02).

There are several aspects of Thakar's work that require special attention. First, the results of the multivariable Cox proportional hazards model suggest that while AKI is a significant risk factor for stage 4 CKD, it also has the same magnitude of risk as proteinuria (defined as an either urinary microalbumin concentration of >30 mg/g creatinine or a protein-creatinine ratio of >0.5 g/g, or a dipstick with >100 mg/dl protein), a well defined risk factor for ESRD in patients with diabetes. This finding suggests that determining a history of AKI in diabetic CKD patients may be on par with proteinuria with regard to assessing risk. Second, the association between AKI and progression of CKD is of similar magnitude irrespective of baseline eGFR, suggesting that an AKI history, even in patients with preserved kidney function, may be a risk marker for adverse renal outcomes.

While Thakar's study demonstrates an association between both solitary and multiple AKI episodes, and an increased risk of reaching stage 4 CKD, it does have limitations. This study does not include information on whether patients with an AKI episode required temporary dialysis or on its duration, a likely strong effect modifier. Also not reported is the number of individuals who progressed to ESRD and required chronic renal replacement therapy by the end of the study, an outcome of significant importance to both patients and clinicians. Finally, it is likely that this study overestimates the risk of developing stage 4 CKD but not of mortality. Individuals with CKD have fluctuations in their serum creatinine levels, potentially resulting in temporary eGFR drops. These temporary declines of eGFR likely are not the result of CKD stage progression, as they are not likely representative of the patient's true eGFR. It is possible that a number of individuals with these transient nonsustained dips in kidney function, either from variation around their baseline or from undergoing outpatient AKI episodes, are flagged as having achieved stage 4 CKD, potentially magnifying the risk attributable to AKI. Finally, it remains unknown how AKI episodes are associated with progressive CKD. Could it be that individuals with progressive kidney disease have an increased risk of AKI, in which case the AKI episode is simply a marker of progressive kidney disease? Alternatively, AKI may not be causal of progressive kidney disease or ESRD but may identify individuals who fail their renal “stress test” based on their limited renal reserve. Irrespective of whether AKI is simply a marker or causal of progressive kidney disease, its presence identifies a high-risk population of patients likely to have progressive kidney disease. Using AKI episodes to identify patients at high risk for kidney disease progression is appealing, as it is relatively easy to ascertain and enables therapies be to be targeted at those most likely to benefit.

In summary, AKI, previously thought to be a relatively benign process without significant long-term sequelae, has been recently identified as a long-term risk factor for CKD, ESRD, and mortality. This knowledge leads—as scientific findings always do—to more questions. For example, is it now possible to classify an entire subset of CKD as due to AKI? Given that AKI is a strong marker of individuals who will have future episodes of AKI and ESRD and will die, should patients with a single AKI episode be systematically followed by a nephrologist?

Disclosures

None.

Footnotes

  • See related article, “Acute Kidney Injury Episodes and Chronic Kidney Disease Risk in Diabetes Mellitus,” on pages 2567–2572.

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • Copyright © 2011 by the American Society of Nephrology

References

  1. 1.↵
    1. Parikh CR,
    2. Coca SG,
    3. Wang Y,
    4. Masoudi FA,
    5. Krumholz HM
    : Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 168: 987–995, 2008
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. James MT,
    2. Ghali WA,
    3. Knudtson ML,
    4. Ravani P,
    5. Tonelli M,
    6. Faris P,
    7. Pannu N,
    8. Manns BJ,
    9. Klarenbach SW,
    10. Hemmelgarn BR
    : Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation 123: 409–416, 2011
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Lo LJ,
    2. Go AS,
    3. Chertow GM,
    4. McCulloch CE,
    5. Fan D,
    6. Ordonez JD,
    7. Hsu C
    : Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893–899, 2009
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Hsu C,
    2. Chertow GM,
    3. McCulloch CE,
    4. Fan D,
    5. Ordonez JD,
    6. Go AS
    : Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4: 891–898, 2009
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Newsome BB,
    2. Warnock DG,
    3. McClellan WM,
    4. Herzog CA,
    5. Kiefe CI,
    6. Eggers PW,
    7. Allison JJ
    : Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 168: 609–616, 2008
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ishani A,
    2. Nelson D,
    3. Clothier B,
    4. Schult T,
    5. Nugent S,
    6. Greer N,
    7. Slinin Y,
    8. Ensrud KE
    : The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 171: 226–233, 2011
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Nath KA,
    2. Croatt AJ,
    3. Haggard JJ,
    4. Grande JP
    : Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult. Kidney Int 57: 2423–2433, 2000
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Basile DP,
    2. Fredrich K,
    3. Alausa M,
    4. Vio CP,
    5. Liang M,
    6. Rieder MR,
    7. Greene AS,
    8. Cowley AW
    : Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288: F953–F963, 2004
    OpenUrl
  9. 9.↵
    1. Thakar CV,
    2. Christianson A,
    3. Himmelfarb J,
    4. Leonard AC
    : Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol, 2011, 2567–2572
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 6 (11)
Clinical Journal of the American Society of Nephrology
Vol. 6, Issue 11
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Acute Kidney Injury and Chronic Kidney Disease: A Work in Progress
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acute Kidney Injury and Chronic Kidney Disease: A Work in Progress
Jason R. Bydash, Areef Ishani
CJASN Nov 2011, 6 (11) 2555-2557; DOI: 10.2215/CJN.09560911

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Acute Kidney Injury and Chronic Kidney Disease: A Work in Progress
Jason R. Bydash, Areef Ishani
CJASN Nov 2011, 6 (11) 2555-2557; DOI: 10.2215/CJN.09560911
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Opportunities for Improvement in Quality of Care of PD-Related Peritonitis in Children
  • Assessing Genetic Risk for IgA Nephropathy
  • Optimizing Utilization of Kidneys from Hepatitis C–Positive Kidney Donors
Show more Editorials

Cited By...

  • Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI
  • Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
  • Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review
  • Development of an Immunoassay for the Kidney-Specific Protein myo-Inositol Oxygenase, a Potential Biomarker of Acute Kidney Injury
  • Google Scholar

Similar Articles

Related Articles

  • Acute Kidney Injury Episodes and Chronic Kidney Disease Risk in Diabetes Mellitus
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire